# ShapeScale Gain insights into your body with an AI-powered, photorealistic 3D body scanner ## Elevator pitch ShapeScale is a weight scale that digitizes your body in 3D, so you can see exactly how your body is changing over time. It creates a photo-realistic 3D model of you that shows exactly where you have been gaining muscles or losing fat. Partnered with our app, you can track which exercises and diets are working for you and optimize your fitness. - Canonical URL: https://wefunder.com/shapescale - Entity ID: wefunder:company:9681 - Last updated: 2026-06-25T05:01:13Z - Generated at: 2026-06-25T11:54:30Z ## Quick facts - Generating $900K in ARR and achieving over 30% month-over-month growth over the past 14 months. - Over 375 business clients including doctors offices, weight loss centers, medical spas and gyms. - ShapeScale is in mass production with over 1000 units produced in 2024 - Strong consumer interest with 4,750 pre-orders and an NPS over 70 from initial shipments. - Over 12,000 users have improved their body shape and health through ShapeScale - Won the Good Design Award (US), a prestigious honor celebrating excellence in product design. - Featured in Men's Fitness, The Verge, Engadget, Techcrunch, Cnet and dozen podcast interviews. - Driven by the rising popularity of GLP-1 agonists, projected to reach 100M users in the US ## Active fundraises - wefunder:fundraise:130884: 4(a)(6) open (USD) - wefunder:fundraise:5674: 4(a)(6) successful (USD) ## Story We’re excited to present the opportunity to invest in ShapeScale’s $1M round. ShapeScale is revolutionizing health and fitness with its 3D body scanning technology, providing actionable, data-driven insights for both businesses and consumers. • Traction: $900K ARR with 30% month-over-month growth over 15 months. Revenues grew 3000% YoY to $1M+ in 2024. • Market Potential: Capturing just 10% of Peloton or Oura’s 5M users will yield a $100M+ ARR business. • Strong Engagement: We are reaching 12,000 users. Customers love it, use it consistently, and businesses pay for it. • Backed by Leaders: Supported by Y Combinator, StartX, Alsop Louie Partners, and more.ShapeScale is raising $1M to scale from $1M ARR to $3M ARR. Join us in transforming health and fitness with a proven product and market demand.The Problem For the past 50 years, people have relied on traditional weight scales—and they simply don’t work!We don't know how our body and body shape change over time.When you gain or lose pounds, you can't tell where.The issue has grown into a societal challenge: 70% of the U.S. population is now overweight or obese.The SolutionA body scanner that shows you where you lose the pounds and what they are made of!ShapeScale create a 3D photorealistic digital record of your body and provides insight on where and how your body has been changing over time. It combines the functions of a DEXA scan, before-and-after photos, tape and volume measurements and weight scale all in a one-minute scan.Here is a video of ShapeScale in action:Why Now?Something fascinating is unfolding: weight loss treatments are experiencing explosive growth, reshaping the fitness, medical spa, weight loss clinic, and plastic surgery markets. Currently, 80% of these businesses now offer medicated weight loss programs—even Equinox has joined the trend. With oral versions of these medications expected to launch in 2026, this movement is poised to reach an even broader audience. Weight loss now sits at the crossroads of aesthetics, fitness, and health—precisely where ShapeScale excels.GrowthGLP-1 treatments have opened the door to a thriving market for us. In just one year, we’ve grown from a few pilot locations to over 375 medical spas, gyms, and weight loss clinics across the U.S. Ultimately, everyone will have a ShapeScale in their home. For now, businesses are paying us to build our consumer base! In fact, we are already reaching over 12,000 users.After doing pilots in 2023 and reaching $48K ARR we have been growing at over 30% MoM during the last 14 months up to $900K ARR (blended).On the consumer side we have 4,750 pre-orders for ShapeScale and its subscription, not only validating our revenue model but also showing that there is significant demand for the such product.2024 Results:We have reached $1M+ in revenues in 2024 and achieved 30x YoY growth.Revenue ModelFor Businesses:The majority of our business customers opt for a subscription model, paying $199 per month with annual billing or $299 per month with monthly billing. Approximately 10% of them purchase ShapeScale outright for $9,780.For Consumers:We sell ShapeScale at home with an attached subscription. It's $999 for the device and $9.99/month for the subscription. With financing the price is $39 / month, less than the price of one personal training session and a third of what you would pay for a Tonal or a Peloton.Product Market FitAt Businesses:xCheck this YouTube playlist for more testimonialsAt Home:We are confident that ShapeScale will be a success in the home. We’ve already shipped units to hundreds of early adopters, and once people begin scanning, they continue to engage. Our NPS with early home users (over 70) rivals industry leaders like Apple (72) and Netflix (67).Unit of economicsOur unit economics are built for scale and profitability. On the B2B side, we’re achieving a 16:1 LTV-to-CAC ratio with a $16K lifetime value and just $1K customer acquisition cost. On the B2C side, we’re seeing an even stronger 18:1 ratio, with $1,800 LTV and only $100 CAC. With churn below 15% annually, our metrics are not just solid—they’re Series B-ready. This is a business model primed for rapid growth and long-term profitability.The big opportunityPeloton (or Oura) have sold over 5 million units. If we capture just 10% of their users, that’s 500,000 ShapeScale customers—enough to generate over $100M in ARR. And the best part? We believe our consumer market extends far beyond that, with massive untapped potential.TeamOur team is the engine behind ShapeScale’s success, bringing together deep expertise in engineering, marketing, and operations. With a track record of launching dozens of products at startups and driving millions in revenue, we have the experience needed to execute and scale. Our team members have honed their skills at industry leaders like Schneider Electric, SpotOn, Phonejoy, Geosatis, to name a few, equipping us with the knowledge and proven ability to bring ShapeScale to market and achieve sustainable growth.VisionOne day, every home will have a body scanner. You’ll just walk in front of it and it will reveal how your body has changed, offering personalized recommendations to help you live healthier, enhance your appearance, and increase your lifespan. Over time, it could even detect up to 80% of diseases earlier than is possible today, paving the way for a new era of preventive healthcare—all from the comfort of your home.Why Invest?ShapeScale is the future of personalized health and fitness. As the demand for cutting-edge, data-driven tools to improve health and aesthetics continues to grow, we are leading the charge in transforming how people understand and enhance their bodies. Backed by top investors including Y Combinator, StartX, Alsop Louie Partners, Rebel Fund, and Alumni Ventures, we’ve experienced remarkable growth, generating $900K in ARR and achieving over 30% month-over-month growth over the past 14 months, cementing our position as a leader in body imaging technology.The AskWe’ve spent the last year de-risking the business: the product works, people love it, it generates value for businesses that pay for it, and consumers are asking for it in their homes. When we sell it to them, they start scanning—and they don’t stop. All we need now is capital to grow. We are raising $1M to scale from $1M ARR to $3M ARR, with half of this amount already committed by key opinion leaders and doctors who believe in the product.Additional information:Medical AdvisorsWe’re honored to have renowned experts on our Medical Advisory Board, including: • Dr. Renato Saltz: A globally recognized plastic surgeon based in Salt Lake City and a former president of ASAPS and ISAPS. Dr. Saltz’s pioneering work in body contouring and comprehensive aesthetic care makes him an invaluable guide as ShapeScale evolves. • Dr. Johnny Franco: A board-certified plastic surgeon and thought leader in Austin, Texas, specializing in body contouring and facial aesthetics. Dr. Franco’s expertise in cosmetic surgery and weight loss practices provides invaluable insights into ShapeScale’s applications in both aesthetics and health. • Dr. Daniel Gould: A distinguished plastic surgeon from Beverly Hills known for advanced reconstructive and cosmetic procedures. Dr. Gould’s innovative techniques and dedication to enhancing natural beauty align perfectly with ShapeScale’s mission. • Terri Ross: An internationally acclaimed consultant in the aesthetics and medical spa industry. With over 20 years of experience, Terri brings unparalleled expertise in operational excellence, patient experience, and strategic growth, ensuring ShapeScale scales effectively to meet the demands of the medical and aesthetic markets.TechWe’re developing a revolutionary computer vision-driven body scanning solution to achieve three key objectives: 1. Effortless Scanning: Simplify the process so users can be captured seamlessly “on the fly.” 2. Health Insights: Build a medical dataset linking 3D scans with anatomical data for actionable insights. 3. Deeper Understanding: Learn the 3D structure and semantics of the human body.Powered by non-rigid body reconstruction, anatomical data correlation, and 4D multi-spectral capture, this technology enables at-home health tracking and earlier detection of diseases.We hold three granted patents that protect our scanning technology and underlying innovations.Our initial work with medical datasets has demonstrated that we outperform current market leaders. For instance, using our dataset of 1,000 DEXA scans, we can estimate body composition with exceptional accuracy.ManufacturingWe have built a 10,000 sq ft manufacturing, assembly and testing facility with our manufacturing partner. It has the capacity of producing up to 40,000 units per year.The impact of our WefunderLooking at the side-by-side comparison of our original prototype and the current ShapeScale, the progress is clear. What started as a bold idea is now a reality—thanks to our incredible Wefunder investors.Your early belief and support made it possible to turn sketches and rough concepts into a sophisticated product that’s changing lives. You laid the foundation for everything we’ve achieved, and we couldn’t have done it without you.Thank you for your trust, support, and for being a vital part of our journey. ## FAQ 1. **How do you justify your valuation without any sales?** - That's a great question and thank you for considering investing! 👍 Unlike for later stage companies an early stage startup's valuation is not entirely dependent on its revenue. We expect our investors to take a long-term view at where we can be ten years from now. Having said that, there are a few other key indicators that can help evaluating a pre-revenue startup such as: (1) Traction and expected near-term revenues: over 40k sign ups which are set to grow to 100k prior to our pre-order laun... 2. **Why no discount rate?** - I'm assuming you are referring to a discount on the SAFE. None of our existing investors have a discount rate and it's the first time we are being asked for one. It's just not something we offer at this stage. 3. **What patents or elements of the technology are you in control of?** - At this point we cannot disclose too much in public about our IP. We are currently working with a renowned Silicon Valley patent attorney. However, ShapeScale has multiple patentable aspects including our software algorithms, software user experience, scanning tech, and mechanical design. 4. **Second query Alexandre- what firm did you use to distribute and spread the word for your video that garnered 1M views in its first day?** - All done in-house. The video and the marketing. We spend a lot of time researching our audience by testing the product through our internal pilots as well as the messaging on Facebook. Basically we crafted an ad with the features that we understood would resonate most with our core audience. We actually didn't have to spend a lot of money on advertising because for each paid view we would achieve eight organic views due to the high engagement on Facebook. We believe we can quickly achieve pro... 5. **You had/have great social media exposure 1M views, 40K signups. Why didn't you take pre-orders from day 1? And if it's set to grow to 100K signups, why not start taking pre-orders now?** - It's simple: because we can do better. ✌️ We have managed several product launches before and it's important to have a great amount of momentum during your first two launch weeks. That way you can reap ripple effects and build a large campaign. Moreover email acquisition of a qualified audience is never going to be cheaper than now because people are eager to sign up because they want to get the product. The email list will have long lasting value for direct marketing and advertising retarget... ## Team - Alexandre Wayenberg (CEO) - Martin Kessler (COO) - Philippe Retornaz (Head of Software) - Lilla Laczo (Senior Marketing) - Feliks Yaretskiy (Lead Backend Engineer) - Leonardo Kaminski Ferreira (Lead iOS Engineer) - Kate Wayenberg (Data Scientist) - Alexander Lux (Global Sourcing Manager) - Xavier Ducourneau (Marketing Specialist) ## Q&A - Q: Finally an update after ghosting investors for 4 years? I can almost guarantee the company is about to ask us all for more money. I fully expect that this company will ghost us again as soon as the funding round closes, since they already have shown us what they think of us. - A: Hi Andrew, I understand your frustration, but I want to clarify that we have provided updates for 2022, 2023, and 2024. Our primary focus has been on building and growing the company, and while we may not always provide frequent updates, we remain committed to delivering value to our investors. Our goal has never been to “ghost” investors but to ensure we are using our time and resources effectively to create a successful outcome for everyone involved. This has nothing to do with how we view our investors—we deeply appreciate everyone who has supported us along the way. As you may have noticed, our campaign page has been updated over the past few days, so our upcoming campaign should come as no surprise. Now that our operations have scaled and our progress is more structured, it makes sense to provide more regular updates. Moving forward, we will aim to share quarterly updates with Wefunder investors to keep everyone better informed. That said if you’re unsatisfied with your investment, please feel free to reach out to me directly at alex@shapescale.com, and we can discuss a potential buyout. - Q: It’s been some years. I sent a message a little while back and still haven’t received any answers, no explanations, how it’s been. NOTHING!!!!!! - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: What is the status of your company? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: Is the company still alive and delivering the product to customers who paid for the product? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Yes we have started to deliver the product to consumers who pre-ordered the product and we are in use at close to 400 business locations. Please refer to the updates tab for the latest update. - Q: ITS 2020 WHERE YALL AT??? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: Investor updates??? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: HELLO?? Any Updates?? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: HELLO?? Any Updates?? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: What is status of this product - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Product is shipping! Please refer to the updates tab for the latest update. - Q: Hello, It's been some time since I made an investment and haven't seen or been aware of any updates? How close are investors to getting an ROI from the company? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update. - Q: How do you justify your valuation without any sales? - A: That's a great question and thank you for considering investing! 👍 Unlike for later stage companies an early stage startup's valuation is not entirely dependent on its revenue. We expect our investors to take a long-term view at where we can be ten years from now. Having said that, there are a few other key indicators that can help evaluating a pre-revenue startup such as: (1) Traction and expected near-term revenues: over 40k sign ups which are set to grow to 100k prior to our pre-order launch. (2) Growth and Engagement: high virality and engagement of our teaser. (3) The founding team: experienced hardware founders. (4) Market size: personal health is a market of strong growth and high spending-power per customer. (5) Competition: Low; we have the potential to create a monopoly and platform. (6) Quality of Investors: We are backed by Y Combinator, the most successful startup accelerator. (7) Comparables: It's not an atypical valuation, when you look at other companies in our space. We hope you find this explanation useful! - Q: Any prospects for an exit strategy? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. I cannot make comment regarding future rounds or timing for ROI at this time. Please refer to the updates tab for the latest update sent on Jan 3, 2025. - Q: Team, please post an update on the progress? it is already Q2 2021 ! - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. We have sent many updates since Q2-2021. Please refer to the updates tab for the latest update sent on Jan 3, 2025. - Q: Updates for INVESTORS?!?!? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. Please refer to the updates tab for the latest update sent on Jan 3, 2025. - Q: Hello, it's been a while and I'd like an update on how Shapescale is doing and when investors will see some return on their original investments? - A: Apologies for the delay in responding! We’re addressing this now to ensure no questions go unanswered. I cannot make comment regarding future rounds or timing for ROI at this time. Please refer to the updates tab for the latest update sent on Jan 3, 2025.